This Joint Action will be carried out by 24 EU National Competent Authorities accross Europe. This large consortium allows a great representation, but also promising exchanges of good practices.

Thanks to this homogeneous coverage of the EU territory, the JAMS 2.0 outcomes and deliverables should be disseminated easily. Consequently, it will support the implementation the Union policies at national level.

The consortium includes a variety of market surveillance roles (inspectors, vigilance assesors, data scientists, project coordinators, etc.), with both senior and junior profiles. The activities planned within the different WPs will create opportunities for close collaboration and foster the development of skills and capacity across the network.

The following agencies took part in the Joint Action for Reinforced Market Surveillance of Medical Devices and In Vitro Medical Devices (JAMS 2.0), contributing in a variety of ways to the outcomes of this work.

Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.